Biểu đồ giá cổ phiếu 02137.HK
BRII-B (02137.HK)
Brii Biosciences Limited
HK$1.34
0%
$0
Thị trường đóng cửa: May 08, 16:00:00 HKT
Quay lại
Brii Biosciences Limited (02137.HK)
Thống kê chính
Giá đóng cửa trước
$1.38
Giá mở cửa
$1.34
Phạm vi ngày
$1.34 - $1.36
Phạm vi 52 tuần
$1.28 - $2.54
Khối lượng
309.5K
Khối lượng trung bình
1.2M
Tỷ suất cổ tức
--
EPS (TTM)
-0.59
Vốn hóa thị trường
$965.8M
BRII-B là gì?
Brii Biosciences Ltd. engages in advancing therapies for significant infectious diseases and other illnesses which have significant public health burdens. The company is headquartered in Beijing, Beijing and currently employs 96 full-time employees. The company went IPO on 2021-07-13. The firm's main products include BRII-179, a candidate drug for hepatitis B virus (HBV) immunotherapy, Tobevibart, an investigational neutralizing monoclonal antibody targeting hepatitis B surface antigen (HBsAg), as well as soralimixin (BRII-693), a synthetic lipopeptide for treating multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacterial infections. The firm primarily operates its businesses in the domestic market.
